# Yuyang Liu

> Yuyang Liu is a Series B investor at Nippon Venture Capital backing Consulting and Health Care. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Nippon Venture Capital](https://shizune.co/investors/profile/nippon-venture-capital)
- Total investments: 6
- Last investment: Jun 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/yuyang-liu-a2b3a311a/

Yuyang Liu is a Series B investor at Nippon Venture Capital focused on Consulting and Health Care. Yuyang Liu - Capitalist @ Nippon Venture Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Consulting | 2 | 33% |
| Health Care | 2 | 33% |
| Audio | 1 | 17% |
| Music | 1 | 17% |
| Content | 1 | 17% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 33% |
| Venture - Series Unknown | 2 | 33% |
| Seed | 1 | 17% |
| Funding Round | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Neusignal Therapeutics | Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M | Series B | Jun 30, 2026 |  |
| Grow Rich English School | Grow Rich English School is a specialized English institution designed to help elementary school students build strong language skills and confidently achieve ambitious goals, including successfully passing the Eiken Grade 2 exam through tailored instruction, supportive learning environments, and effective study strategies. | $381.2K | Seed | Nov 20, 2025 |  |
| Surv Biopharma | Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. | $14.1M | Series B | Nov 11, 2025 |  |
| Revorf | Revorf analyzes data and develops AI-related to infectious diseases and healthcare. | $42.1M | Venture - Series Unknown | Aug 26, 2024 |  |
| ProtoStar | ProtoStar connects startups, investors, and business companies. Protostars, which started with the inauguration of the entrepreneurial community, include professionals from various backgrounds such as capitalists, entrepreneurs, consultants, IPOs, and business sellers. | $820.8K | Venture - Series Unknown | Sep 01, 2023 |  |
| CreoFuga | Creofuga is a startup from Japan’s western city of Okayama which has been providing an online community platform for amateur or semi-professional music composers. | $36.9M |  | Mar 02, 2018 |  |

6 of 6 investments shown.

## Co-investors
- [DCI Partners](https://shizune.co/investors/profile/dci-partners) — VC Fund, 3 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 3 deals together
- [FFG Venture Business Partners](https://shizune.co/investors/profile/ffg-venture-business-partners) — VC Fund, 2 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 2 deals together
- [Beyondge](https://shizune.co/investors/profile/beyondge) — VC Fund, 1 deal together
- [Bio Engineering Capital](https://shizune.co/investors/profile/bio-engineering-capital) — VC Fund, 1 deal together

## About Nippon Venture Capital

VC Fund · Tokyo, Japan

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

5 contacts available at Nippon Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Anzai Hiroaki | Venture Capitalist | https://shizune.co/investors/profile/anzai-hiroaki |
| Chihiro Kanagawa | Director | https://shizune.co/investors/profile/chihiro-kanagawa |
| Kakiuchi Shingo | General Manager | https://shizune.co/investors/profile/kakiuchi-shingo |
| Yuko Kitaoka | Senior Partner | https://shizune.co/investors/profile/yuko-kitaoka |
| Yuyang Liu | Capitalist | https://shizune.co/investors/profile/yuyang-liu |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Yuyang Liu invest in?

Yuyang Liu invests primarily in Consulting, Health Care and Audio startups, most often at Series B and Venture - Series Unknown stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yuyang Liu last invest?

The most recent investment recorded for Yuyang Liu closed in Jun 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co